Clinical Chemistry

Kidney Disease Biomarker May Indicate Lung Problems
Chronic lower respiratory diseases (CLRD) are the fourth leading cause-of-death and a major source of health care costs. CLRD includes chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, and asthma, airflow limitation as a physiologic correlate, and acute exacerbations as the major clinical manifestation. More...09 Oct 2018


Blood Tests Differentiate Myocardial Injury from Infarction
Myocardial infarction represents the death of myocardial cells and is characterized by acute myocardial ischemia. Nonischemic myocardial injury by comparison is often associated with other conditions such as renal failure or heart conditions like myocarditis. More...03 Oct 2018

High Blood Sugar During Pregnancy Increases Risk of Diabetes
Mothers with elevated blood glucose during pregnancy, even if not high enough to meet the traditional definition of gestational diabetes, were significantly more likely to have developed type 2 diabetes a decade after pregnancy than their counterparts without high blood glucose. More...02 Oct 2018

Ovarian Cancer Biomarker Predicts Therapy Response
Despite months of aggressive treatment involving surgery and chemotherapy, about 85% of women with high-grade widespread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but never to a cure. About 15% of patients, however, do not have a recurrence and most of those women remain disease free for years. More...01 Oct 2018

Nano-LCMS Differentiates Liver Diseases
Non-alcoholic steatohepatitis (NASH) is among the leading causes of liver disease worldwide. It is increasingly recognized that the phenotype of NASH may involve a number of different pathways, of which each could become important therapeutic targets. More...24 Sep 2018

High-Sensitivity Cardiac Troponin I Assay Validated
Myocardial infarction (MI), commonly known as a heart attack occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. More...20 Sep 2018
In Other News
Novel Biomarkers Predict CV Events in Type 2 Diabetes
Tumor Markers Associated with H. Pylori Infection
Elevated Triglycerides Associated with Risk of PAD
High Levels of Aldosterone Increase Risk of Diabetes
Blood Test Screens for Secondary Heart Attack
New Biomarker Panel Could Accelerate Autism Diagnoses
Residual Tissue Repositories Suitable for MS-Based Proteomics
Prognostic Biomarkers Identified for Aggressive Breast Cancer
Biomarker Low Predictive Power Validated for eGFR Decline
Inflammation Biomarkers Identified as Risk of Polyneuropathy
Sleep Disorder Linked with Abnormal Lipid Levels
Serum S-100β Elevated in Septic Shock Patients with Delirium
Blood Test Identifies Gestational Diabetes Risk in First Trimester
Biomarkers Explored in Patients with Acute Coronary Syndromes
Sensitive Blood Test Diagnoses Heart Attacks Faster
Continuous Glucose Monitoring System Offers Improved Accuracy
Biochemical Markers Predict Risk of Incident Diabetes
Alzheimer’s Disease Risk Impacted by Liver and Diet
Fifth-Generation Cardiac Troponin Assays Compared
Time To Blood Culture Positivity Predicts Infective Endocarditis
Breath Test Detects Early-Stage Parkinson's Disease
Test Enables Quick Diagnosis for Rare Hormone Disorder
Diagnostic Tool Created for Hypoglycemia-Associated Autonomic Failure
The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.